HCLSIG/LODD/Meetings/2008-12-10 Conference Call

Conference Details

Date of Call: Wednesday December 10, 2008
Time of Call: 11:00am Eastern Daylight Time (EDT), 16:00 Greenwich Mean Time (GMT), 17:00 Central European Time (CET)
Dial-In #: +1.617.761.6200 (Cambridge, MA)
Dial-In #: +33.4.89.06.34.99 (Nice, France)
Dial-In #: +44.117.370.6152 (Bristol, UK)
Participant Access Code: 4257 ("HCLS").
IRC Channel: irc.w3.org port 6665 channel #HCLS (see W3C IRC page for details, or see Web IRC)
Duration: ~1h
Convener: Susie

Attendees: Matthias, TN, Oliver, Jun, Bosse, Don, Susie

<Susie> Jun presents on incorporating alternative medicine into the use case

<Susie> Jun: maybe try to use a newer version of dbpedia

<Susie> Jun: Infobox contains richer information in Chinese

<Susie> Jun: Kei and Jun thinking about doing further enrichment of the information

<Susie> Jun: I'll continue to do work in this area

<Susie> Don: explored which data sets look interesting for bridging drug and disease

<Susie> Don: Linkages were fairly sparse

<Susie> Don: Drugbank linking was best trhough the indication identifier

<Susie> Don: Couldn't find links in data sets to OMIM

<Susie> Don: DailyMeD - indication and usage identfiers look like best spot for disease

<Susie> Don: the matrix wasn't particularly strong

<Susie> Natural link from drug to indication; not from drug to disease

<Susie> Bosse: link to indication is interesting

<Susie> Bosse: could find connections across disease

<Susie> Don: Will continue to work to identify linkage points

<Susie> Bosse focused on " "Am I suitable for this clinical trial in terms of my location, ethnic background, and other inclusion criteria?" "

<Susie> Bosse: struggled to get beyond ClinicalTrial.gov

<Susie> Bosse: could expand to "with my profile what other information is useful"

<Susie> Bosse: start my defining a persons profile

<Susie> Bosse: focus on important inclusion and exclusion criteria, eg age, gender, sympotms

<Susie> Bosse: try to get a profile to share

<Susie> Susie: Clinicaltrials.gov & lillytrials are main sources of information on trials

<Susie> Bosse: some data sources have stringent reuse policies

<Susie> The group will continue to focus on identifying use cases that are focused on patients

<Susie> Susie: Provided re-cap of the goals of the group

<Susie> Don: Should identify timeline for deliverables

<Susie> Susie: Timeline could also be driven by a presentation opportunity

<Susie> Susie: Next call on January 7